Liver kinase B1 (LKB1) as a tumor suppression gene that is associated with various kinds of cancers, including lung cancer. In this study, we found that the effect of In contrast, high nuclear expression of LKB1 is associated with early TNM stage and longer OS. The high level of cytoplasmic LKB1 expression was an independent risk factor for poor overall survival in patients with adenocarcinoma. Together, our results revealed that cytoplasmic LKB1 promotes the growth of lung adenocarcinoma and could be a prognostic marker for lung adenocarcinoma. -
LKB1 occurs in many types of sporadic cancers, such as lung cancer, 4 breast cancer, 5 and pancreatic cancer, 6 suggesting that LKB1 acts as a tumor suppressor. Inactivation of LKB1 and altered levels of LKB1 expression are detected in NSCLC tissues. 7 However, it is unclear what the function of different subcellular LKB1 is in NSCLC.
Autophagy is an intracellular process of cytoplasmic component degradation in the lysosome to renew some organelles and maintain metabolic homeostasis. 8, 9 During the process of autophagy, stimuli can initiate the formation of autophagosome, a double-membraned vesicle containing cytoplasmic contents and organelles, and its outer membrane will fuse with a lysosome to form an autolysosome to degrade the contents. 10 Autophagy can regulate cell proliferation, apoptosis, and drug sensitivity in tumor cells. 11 However, the precise effects underlying the regulation of autophagy on proliferation and apoptosis of NSCLC are still unclear. Furthermore, LKB1 acts as an upstream kinase for AMP-activated protein kinase (AMPK) and PI3K/ AKT/mTOR signaling. 12 It is poorly understood how the cytoplasmic and nuclear LKB1 and related signaling regulate the autophagy, proliferation, and apoptosis of NSCLC cells.
| MATERIALS AND METHODS

| Patients
One hundred and ninety patients with lung adenocarcinoma were recruited from the First Affiliated Hospital of Xi'an Jiao Tong 
| Immunohistochemical staining
The freshly dissected human lung adenocarcinoma and mouse transplanted tumors were fixed in 10% buffered formalin overnight and paraffin-embedded. The tumor tissue sections (5 μm) were deparaffinized and rehydrated, followed by antigen retrieval in a microwave oven. The sections were incubated in 3% hydrogen peroxide in methanol for 10 minutes to inactivate endogenous peroxidase, blocked with 10% normal goat serum for 20 minutes at room temperature, and incubated with anti-LKB1 samples with a score of 6-12 were defined as having high levels of expression. The intensity of nuclear anti-LKB1 staining was defined as: 0, no staining; 1, staining. The percentages of nuclear-stained cells were defined as 0, <5%; 1, 5%-37%; 2, 38%-70%; and 3, >70%.
A final score of <1 was defined as no nuclear LKB1 expression, whereas a final score of >2 was defined as expressing nuclear LKB1.
| Cell culture and transfection
Human lung adenocarcinoma A549 and HCC827 cells were cultured in DMEM containing 10% (v/v) FBS at 37°C in 5% CO 2 . All the vectors contained the kanamycin/G418 resistance gene. When the cells reached 70% confluency, they were transfected with individual expression plasmids using the TurboFect transfection reagent 
| Western blot analysis
The different groups of cells were lysed in RIPA lysis buffer (Beyotime Chemical, Beijing, China). In addition, nuclear and cytoplasm proteins were extracted from the different groups of cells using the Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime Chemical).
After quantification of protein concentrations, the protein samples Upland, CA, USA).
| Cell proliferation assay
The different groups of cells (2 × 10 3 cells/well) were cultured in 96-well plates overnight, and the proliferation of each group of cells was determined by MTT assay. Briefly, each well of cells was exposed to 5 mg/mL MTT for 6 hours daily for 7 days and the generated formazan in individual wells was solubilized by adding 150 μL DMSO, followed by measuring the optical density at 492 nm in a microplate reader. The experiments were carried out in triplicate, and control and experimental cells were tested simultaneously.
| Colony formation assay
The 
| Transmission electron microscopy
Autophagosomes in individual cells were detected by transmission electron microscopy (TEM). Briefly, the cells were harvested and the cell pellets were fixed by 2.5% glutaraldehyde for 2 hours at 4°C.
After dehydrated by acetone, these cell pellets were embedded and placed in 65°C for 2 hours. The cell ultrathin sections (50-70 nm)
were stained by sodium acetate and lead citrate, then observed under using TEM. Autophagosomes were counted in 5 high power fields (×20 000) to obtain the average number of autophagosomes for each sample.
| Lung cancer xenograft in nude mice
Male BALB/c nude mice at 4 weeks of age were purchased from the Animal Center of Xi'an Jiaotong University and housed in a specific pathogen-free facility with free access to autoclaved food and water.
To establish xenograft tumors, individual mice were randomized and Together, these data indicated that cytoplasmic LKB1 promoted autophagy, which was associated with enhanced proliferation in A549 and HCC827 cells.
| Autophagy enhanced by cytoplasmic LKB1 is independent of AMPK/mTOR signaling in A549 and HCC827 cells
It is well known that AMPK/mTOR signaling regulates autophagy, particularly in a nutrition-deficient condition. 13 To further understand the regulation of cytoplasmic LKB1 on autophagy, the relative levels of AMPK and mTOR were determined by western blot analysis. We (31.8%) with nuclear LKB1 expression ( Figure 7 , Table 1 ). The frequency of cancers with nuclear LKB1 and low levels of cytoplasmic LKB1 expression was significantly lower than those without nuclear LKB1 and high levels of cytoplasmic LKB1 expression (Table 2) . Stratification analysis indicated that cytoplasmic LKB1 expression was positively associated with T stage (P = .01) and TNM stage (P = .045; Table 3 ) in this cohort. Furthermore, the nuclear LKB1 expression was associated inversely with T stage (P = .028) and TNM stage (P = .023, Table 3 ) in this cohort. More importantly, patients with higher levels of cytoplasmic LKB1-expressing lung cancer had significantly shorter OS than those with lower levels of cytoplasmic LKB1-expressing cancers ( Figure 8A , P < .001). In contrast, patients with negative nuclear LKB1-expressing lung cancers had significantly shorter OS than those with nuclear LKB1-expressing cancers ( Figure 8B , P < .001). Further analysis indicated that the patients with nuclear and lower levels of cytoplasmic LKB1-expressing lung cancers had the longest OS and the patients with either lower levels of cytoplasmic LKB1, but without nuclear LKB1, or nuclear and higher levels of cytoplasmic LKB1-expressing lung cancers had similar OS, whereas those with higher levels of cytoplasmic LKB1, but without nuclear LKB1-expressing lung cancers had the shortest OS in this population ( Figure 8C , P < .001). Finally, univariate analysis indicated that age at diagnosis (<60 years old), lepidic lung adenocarcinoma, and nuclear LKB1 expression were associated with a longer OS, whereas advanced T and TNM stages, lymph node metastasis, and cytoplasmic LKB1 expression were associated with a shorter OS in this cohort (Table 4 ). Multivariate analysis revealed that age at diagnosis (<60 years old), lepidic lung adenocarcinoma, and nuclear LKB1 expression were independent factors for a longer OS, whereas advanced TNM stages and cytoplasmic LKB1 expression were independent risk factors for a shorter OS in this cohort (Table 4) . Collectively, our data indicated that subcellular localization of LKB1 was an independent biomarker for prognosis of patients with lung adenocarcinoma. F I G U R E 8 High levels of cytoplasmic liver kinase B1 (LKB1) expression are associated with poor overall survival in lung adenocarcinoma.
Patients with lung adenocarcinoma were stratified, based on the distribution and levels of LKB1 expression, and their overall survival was established by the Kaplan-Meier method, followed by log-rank test. A, overall survival of low cytoplasmic LKB1 group and high cytoplasmic LKB1 group. B, overall survival of positive nuclear LKB1 group and negative nuclear LKB1 group. C, overall survival of low cytoplasmic LKB1 with nuclear LKB1 group, low cytoplasmic LKB1 without nuclear LKB1 group, high cytoplasmic LKB1 with nuclear LKB1 group and high cytoplasmic LKB1 without nuclear LKB1 group
In this study, we found that cytoplasmic LKB1 promoted the growth of lung adenocarcinoma by enhancing autophagy. First, we showed that induction of truncated LKB1 s was exclusively expressed in the cytoplasm, and full-length LKB1 was expressed in both cytoplasm and nucleus of A549 and HCC827 cells. The relationship between autophagy and cancer is complicated.
Previous studies have found low levels of autophagy in cancer cells due to the mutation, deletion, and functional inhibition of autophagyrelated genes. 14 Autophagy can inhibit the process of carcinogenesis by degrading harmful proteins and damaged organelles, reducing the instability of the genome, or converging inflammatory responses induced by necrosis. 15 Inhibition of autophagy is associated with promoting cell differentiation, protein catabolism, and autophagic cell death. 16 However, our findings could be surprisingly against the traditional dogma. It is possible that autophagy induced by LKB1 s may help cancer cell survival under a nutrition deficiency circumstance to overcome metabolic stress and maintain energy balance.
It is well known that LKB1 can activate AMPK. Activation of AMPK can inhibit mTOR and further enhance autophagy. 17 In this study, we found that cytoplasmic LKB1 s enhanced autophagy, independent of AMPK and mTOR signaling. The full-length LKB1 localizes in the nucleus. It interacts with STe20 Related Adaptor in the nucleus to form a dipolymer complex and the complex relocates from the nucleus to the cytoplasm where the complex binds to MO25 and forms a tripolymer complex, leading to AMPK activation. 18 As the short form of LKB1 has no normal nuclear localization signal, so it cannot form a tripolymer complex and fails to activate AMPK. Although mTOR signaling is an important negative regulator of autophagy and the AMPK/ mTOR pathway can be activated by LKB1, the independence of cytoplasmic LKB1 s promoting autophagy suggests that cytoplasmic LKB1 might enhance autophagy by other pathways or stimuli. Actually, previous studies have shown that the Bcl-2 family, 19 p53 protein, 20 oxidative stress, 21 and endoplasmic reticulum stress 22 can enhance autophagy. We are interested in further investigating the precise mechanisms underlying the action of LKB1 s in promoting cell autophagy and the growth of lung adenocarcinoma cells.
To look for clinical significance, we characterized LKB1 expression in 190 lung adenocarcinoma samples. We found that LKB1 was expressed in both the nucleus and cytoplasm of lung adenocarcinoma. Interestingly, the levels of nuclear LKB1 were inversely associated with cytoplasmic LKB1 in lung adenocarcinoma. Furthermore, cytoplasmic LKB1 was associated with poor OS in this population and was an independent risk factor for prognosis.
In summary, our data indicated that cytoplasmic LKB1 promoted A549 and HCC827 cell survival in vitro and in vivo. Furthermore, cytoplasmic LKB1 was associated with poor prognosis in lung adenocarcinoma cancer. Therefore, our findings could provide new insights into the pathogenesis of lung adenocarcinoma and novel biomarkers for prognosis of lung adenocarcinoma.
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